Cardiac troponin I detection during pregnancy for identification and risk assessment of cardiovascular disease

摘要

The present invention determines whether the sample (cTnI) concentration is higher than the 99th percentile cTnI concentration from the corresponding pregnancy control group without complications 1st, 2nd or 3rd trimester Women who are pregnant by determining whether they are at risk of developing or having cardiovascular disease such as pregnancy hypertension (first trimester, second trimester) The present invention provides a system and method for determining and reporting cardiac troponin I (cTnI) concentration in samples from (phase 3, or phase 3).